Atea Pharmaceuticals Inc [AVIR] stock Upgrade by Morgan Stanley analyst, price target now $6.88
Atea Pharmaceuticals Inc [NASDAQ: AVIR] traded at a low on 2025-08-29, posting a -3.17 loss after which it closed the day’ session at $3.36. The results of the trading session contributed to over 161155 shares changing hands. Over the past one week, the price volatility